Trinetx, based in Cambridge, offers a unique platform that harnesses real-world data from 250 million patients worldwide to enhance study design, facilitate trial collaboration, generate evidence, and ensure drug safety.
The company's innovative approach enables researchers and pharmaceutical companies to access a vast pool of patient data for more informed decision-making and improved outcomes in healthcare research and development.
Generated from their website's infomation